Homeland Nickel

WGC: Gold Demand Tops 5,000 Tons for the First Time on Investment, Central Bank Buying

Global gold demand surged past 5,000 tons in 2025 for the first time on record driven by a historic wave of investment

Nuvau Provides Corporate Update and Strategy for 2026

Building on exploration success at flagship Matagami project Nuvau Minerals Inc. (TSXV: NMC,OTC:NMCPF) is pleased to provide a corporate update, highlighting the success

Syntholene Energy Announces Co-Listing in the United States on OTCQB Market Under Symbol SYNTF

Co-Listing Expands U.S. Investor Access and Visibility in World’s Largest Aviation and Capital Markets Syntholene Energy CORP (TSXV: ESAF,OTC:SYNTF) (OTCQB: SYNTF) (FSE: 3DD0)

CoTec Forms Subsidiary, CoTec Copper, To Accelerate Investment Activities In Copper Tailings and Copper Sulfide Deposits

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 29, 2026 / CoTec Holdings Corp. (TSX-V:CTH)(OTCQB:CTHCF) (‘CoTec’ or the ‘Company’) is pleased to

Blackrock Silver Appoints Sean Thompson as Head of Investor Relations

Blackrock Silver Corp. (TSXV: BRC,OTC:BKRRF) (OTCQX: BKRRF) (FSE: AHZ0) (the ‘Company’ or ‘Blackrock’) is pleased to announce the appointment of Sean Thompson

SAGA Metals Commences 2026 MRE Drill Program at Radar Critical Minerals Project in Labrador

Saga Metals Corp. (‘SAGA’ or the ‘Company’) (TSXV: SAGA,OTC:SAGMF) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral

Romios to Commence Trading Post Consolidation as Oreterra Metals Corp. Under Ticker OTMC on Monday, February 2, 2026

Romios Gold Resources Inc. (TSXV: RG,OTC:RMIOF) (OTCID: RMIOF) (FSE: D4R) (‘Romios’ or the ‘Company’) is pleased to announce that, pursuant to special resolutions passed by

Silicon-Driven Health: AI Digital Twins And The US$1 Billion Pharma Deal

As massive capital flows into the life science sector, two distinct, and potentially opposing, strategic directions have emerged. While NVIDIA (NASDAQ:NVDA) is expanding

Expansion of SVN-015 into Depression Following Positive Preclinical Data

Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (‘CNS’) disorders, announces the expansion